Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma.

Leskela S, Pérez-Mies B, Rosa-Rosa JM, Cristobal E, Biscuola M, Palacios-Berraquero ML, Ong S, Matias-Guiu Guia X, Palacios J.

Cancers (Basel). 2019 Jul 9;11(7). pii: E964. doi: 10.3390/cancers11070964. Review.

2.

High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features.

Rosa-Rosa JM, Caniego-Casas T, Leskela S, Cristobal E, González-Martínez S, Moreno-Moreno E, López-Miranda E, Holgado E, Pérez-Mies B, Garrido P, Palacios J.

Cancers (Basel). 2019 Jan 11;11(1). pii: E74. doi: 10.3390/cancers11010074.

3.

Pleomorphic lobular carcinoma of the breast with osteoclast-like giant cells: a case report and review of the literature.

Peña-Jaimes L, González-García I, Reguero-Callejas ME, Pinilla-Pagnon I, Pérez-Mies B, Albarrán-Artahona V, Martínez-Jañez N, Rosa-Rosa JM, Palacios J.

Diagn Pathol. 2018 Aug 28;13(1):62. doi: 10.1186/s13000-018-0744-6. Review.

4.

Histological changes secondary to wire coil placement in breast tissue and lymph nodes.

Pinilla-Pagnon I, Pérez-Mies B, Reguero ME, Martinez MT, Chiva M, Pérez-Rodrigo S, Illarramendi OA, Martin MER, Collado MV, Sanchez MC, Rosa-Rosa JM, Palacios J.

Virchows Arch. 2018 Sep;473(3):285-291. doi: 10.1007/s00428-018-2399-9. Epub 2018 Jul 8.

PMID:
29984379
5.

Treating KRAS-mutant NSCLC: latest evidence and clinical consequences.

Garrido P, Olmedo ME, Gómez A, Paz Ares L, López-Ríos F, Rosa-Rosa JM, Palacios J.

Ther Adv Med Oncol. 2017 Sep;9(9):589-597. doi: 10.1177/1758834017719829. Epub 2017 Jul 24. Review.

6.

VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer.

Castilla MÁ, López-García MÁ, Atienza MR, Rosa-Rosa JM, Díaz-Martín J, Pecero ML, Vieites B, Romero-Pérez L, Benítez J, Calcabrini A, Palacios J.

Endocr Relat Cancer. 2014 Aug;21(4):587-99. doi: 10.1530/ERC-13-0485. Epub 2014 Jun 2.

PMID:
24891455
7.

Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.

Gracia-Aznarez FJ, Fernandez V, Pita G, Peterlongo P, Dominguez O, de la Hoya M, Duran M, Osorio A, Moreno L, Gonzalez-Neira A, Rosa-Rosa JM, Sinilnikova O, Mazoyer S, Hopper J, Lazaro C, Southey M, Odefrey F, Manoukian S, Catucci I, Caldes T, Lynch HT, Hilbers FS, van Asperen CJ, Vasen HF, Goldgar D, Radice P, Devilee P, Benitez J.

PLoS One. 2013;8(2):e55681. doi: 10.1371/journal.pone.0055681. Epub 2013 Feb 8.

8.

A modified method for whole exome resequencing from minimal amounts of starting DNA.

Kozarewa I, Rosa-Rosa JM, Wardell CP, Walker BA, Fenwick K, Assiotis I, Mitsopoulos C, Zvelebil M, Morgan GJ, Ashworth A, Lord CJ.

PLoS One. 2012;7(3):e32617. doi: 10.1371/journal.pone.0032617. Epub 2012 Mar 5. Erratum in: PLoS One. 2012;7(4): doi/10.1371/annotation/5b071c93-9fa8-4be6-9cbd-95aead146305. J, Christopher [corrected Lord, Christopher J].

9.

Deep sequencing of target linkage assay-identified regions in familial breast cancer: methods, analysis pipeline and troubleshooting.

Rosa-Rosa JM, Gracia-Aznárez FJ, Hodges E, Pita G, Rooks M, Xuan Z, Bhattacharjee A, Brizuela L, Silva JM, Hannon GJ, Benitez J.

PLoS One. 2010 Apr 2;5(4):e9976. doi: 10.1371/journal.pone.0009976.

10.

A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer.

Rosa-Rosa JM, Pita G, González-Neira A, Milne RL, Fernandez V, Ruivenkamp C, van Asperen CJ, Devilee P, Benitez J.

Breast Cancer Res Treat. 2009 Nov;118(1):151-9. doi: 10.1007/s10549-009-0317-1. Epub 2009 Feb 10.

PMID:
19205878
11.

Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci.

Rosa-Rosa JM, Pita G, Urioste M, Llort G, Brunet J, Lázaro C, Blanco I, Ramón y Cajal T, Díez O, de la Hoya M, Caldés T, Tejada MI, González-Neira A, Benítez J.

Am J Hum Genet. 2009 Feb;84(2):115-22. doi: 10.1016/j.ajhg.2008.12.013. Epub 2009 Jan 15.

12.

Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies.

Gonzalez-Neira A, Rosa-Rosa JM, Osorio A, Gonzalez E, Southey M, Sinilnikova O, Lynch H, Oldenburg RA, van Asperen CJ, Hoogerbrugge N, Pita G, Devilee P, Goldgar D, Benitez J.

BMC Genomics. 2007 Aug 30;8:299.

Supplemental Content

Loading ...
Support Center